Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

Return to program book search

Session Information

FRM F004 - Hot Topics in Melanoma

Open admission to eligible categories, no tuition or ticket


Date: Friday, March 01

CME Credits: 2.00

Location: Palm Ballroom 4

Time: 10:00 AM - 12:00 PM

Director: Rhoda Myra Alani, MD, FAAD


  • Alan Geller, MPH
  • Sheilagh M. Maguiness, MD, FAAD
  • Daniel D. Miller, MD, FAAD
  • Thomas Michael Ruenger, MD, PhD
  • Debjani Sahni, MBBS, MD

Learning Objectives:
Following this course, the attendee should be able to:

  • Select the best state-of-the-art diagnostic tests for their patients with melanoma
  • Select the best state-of-the-art therapeutic interventions for their patients with melanoma
  • Provide sound recommendations to patients concerning melanoma risks associated with indoor tanning and UV exposures using evidence-based medicine

Melanoma incidence in the US continues to rise despite large-scale media campaigns to promote melanoma awareness and prevention. Recent advances in basic and translational research have allowed for improved methods of melanoma prevention, detection, diagnosis, and treatment, while carefully designed population-based studies have improved our understanding of melanoma risk factors, including UV exposures associated with indoor tanning. Our internationally recognized team of experts will present the most up-to-date information on cutting edge research in melanoma. Participation in this program is expected to improve the clinical management of patients with melanoma and those at high-risk to develop this disease.


Friday, March 01
10:00 AMUVA, UVB and melanoma: Insights from the laboratory / Dr. Ruenger
10:15 AMQuestions & Answers / Dr. Ruenger
10:20 AMIndoor tanning as a risk for melanoma / Geller
10:35 AMQuestions & Answers / Geller
10:40 AMSunscreens as an effective melanoma prevention strategy / Sahni
10:55 AMQuestions & Answers / Sahni
11:00 AMDiagnostic and Prognostic Markers for Melanoma: What's on the horizon / Dr. Miller
11:15 AMQuestions & Answers / Dr. Miller
11:20 AMMelanoma in the Pediatric Population / Dr. Maguiness
11:35 AMQuestions & Answers / Dr. Maguiness
11:40 AMNovel Targeted Melanoma Therapies: Progress and Promise / Dr. Alani
11:55 AMQuestions & Answers / Dr. Alani